Brief: Atyr Pharma Announces First Quarter 2023 Results And Provides Corporate Update

aTyr Pharma

09/05/2023 21:46

May 9 (Reuters) - aTyr Pharma Inc  LIFE.O :
    * ATYR PHARMA ANNOUNCES FIRST QUARTER 2023 RESULTS AND
PROVIDES
CORPORATE UPDATE
    * ATYR PHARMA INC - PHASE 2 PROOF-OF-CONCEPT STUDY OF
EFZOFITIMOD
IN PATIENTS WITH SSC-ILD EXPECTED TO INITIATE IN Q3 OF 2023
    * ATYR PHARMA INC - ENDED Q1 2023 WITH $117.6 MILLION IN
CASH,
CASH EQUIVALENTS AND INVESTMENTS
    * ATYR PHARMA INC -  BASED ON CO'S CURRENT OPERATIONAL PLANS
AND
EXISTING CASH, CO MAINTAINS PRIOR GUIDANCE & BELIEVES CASH
RUNWAY WILL EXTEND INTO 2026
    * ATYR PHARMA INC - QTRLY LOSS PER SHARE $0.29

Source text for Eikon:  ID:nGNX9WKkdd 
Further company coverage:  LIFE.O 

 ((Reuters.Briefs@thomsonreuters.com;))